Skip to main content
. Author manuscript; available in PMC: 2020 Sep 25.
Published in final edited form as: Anesthesiology. 2020 Feb;132(2):253–266. doi: 10.1097/ALN.0000000000003014

Table 3.

Postoperative Data

Variables Control Group
(N = 44)
Closed-loop Group
(N = 45)
Point Estimate
(95% CI)
P Value
Total fluid infusion at postoperative day 1 (ml) 1,325 [400 to 2,638] 1,625 [500 to 2,648] 100 (−300 to 700) 0.534
Major complications, N (%)
 Patients with any major complications 5 (11) 2 (4) −7 (−18 to 4) 0.224
 Pulmonary embolism 1 (2) 0 (0) −2 (−7 to 2) 0.312
 Pulmonary edema 1 (2) 0 (0) −2 (−7 to 2) 0.312
 Pneumonia 2 (5) 0 (0) −5 (−10 to 2) 0.241
 Incidence of acute kidney injury* 4 (9) 2 (4) −5 (−15 to 6) 0.382
 30-day mortality 1 (2) 1 (2) 0 (−6 to 6) 0.987
 90-day mortality 1 (2) 1 (2) 0 (−6 to 6) 0.987
Minor complications, N (%)
 Patients with any minor complications 10 (23) 11 (24) 2 (−16 to 19) 0.849
 Superficial wound infection 1 (2) 1 (2) 0 (−6 to 6) 0.987
 Urinary infection 1 (2) 0 (0) −2 (−7 to 2) 0.312
 Paralytic ileus 1 (2) 1 (2) 0 (−6 to 6) 0.987
 Postoperative confusion 2 (5) 0 (0) −5 (−10 to 2) 0.241
 Posmiddleerative nausea and vomiting 5 (11) 7 (16) 4 (−10 to 18) 0.561
 Other infections 3 (7) 3 (7) 0 (−11 to 10) 0.977
Hemoglobin at discharge (g · dl−1) 11.7 ± 1.7 11.8 ± 2.1 0.1 (−0.8 to 0.9) 0.892
Creatinine at discharge (mg · dl−1) 0.9 [0.7 to 1.0] 0.8 [0.6 to 1.0] −0.1 (−0.2 to 0) 0.052
Estimated glomerular filtration rate at discharge (ml · kg−2 · 1.73 m−2) 85 [74 to 95] 96 [80 to 103] 8 (0 to 15) 0.059
Intensive care or postanesthesia care unit length of stay (h) 6 [3 to 19] 17 [4 to 19] 1 (−1 to 3) 0.419
Hospital length of stay (day) 4 [3 to 7] 4 [3 to 8] 1 (0 to 1) 0.259
90-day readmission 12 (27) 11 (24) −3 (−21 to 15) 0.761

Data are presented as number and percentage, (%) or median [25th to 75th percentiles] or mean ± SD. Point estimates for group differences were estimated for Mann-Whitney U test as the median difference in the set of values representing all differences in pairings between the two groups.

*

Included Kidney Disease Improving Global Outcomes I to III.

Assessed by nurses in the postanesthesia care unit.